News
About 300 people braved icy waters off the New Plymouth coast on Sunday to protest against the Pātea seabed mining project.
BLUETTI just dropped something really big. The new Apex 300 is here, and it’s BLUETTI’s most advanced, modular power station to date. It’s made to grow with you, whether you need backup for ...
Acoramidis is a selective, small molecule, orally administered, near-complete (≥90%) TTR stabilizer. These findings further support the thesis that ever better increases in serum TTR lead to ...
After canceling the upcoming Airflow electric crossover and killing its popular 300 sedan, Chrysler only has one nameplate left in its lineup – but it doesn’t have to be this way. Stellantis ...
A McLean mansion's transformation reveals how high-end realtors are rethinking marketing strategies. A $14M teardown? Welcome to McLean's Gold Coast. A $14M teardown? Welcome to McLean's Gold ...
Acoramidis is a selective small molecule, orally administered near-complete (≥90%) transthyretin (TTR) stabilizer. ATTR-CM is a progressive fatal disease that presents as an infiltrative ...
A team of four D.C. real estate agents who’ve listed and sold some of the D.C.-area’s most high-profile, multimillion-dollar homes has moved their shingle to TTR Sotheby’s after years of ...
The company provided 2025 guidance for TTR product sales of $1.6 billion to ... to reach $650 million to $750 million, supported by a $300 million milestone payment from Roche.
The presence of genetic variants that affect the stabilization of the tetrameric protein transthyretin (TTR) is associated with both all-cause and cardiovascular mortality, according to new data from ...
Honor's 300 series is official with the 300, 300 Pro, and 300 Ultra, all with emphasis on the portraits. All three phones feature 50MP main cameras and, more importantly, a 50MP f/2.1 selfie camera.
These new results demonstrated that a single dose of nucresiran at 300 mg or higher led to rapid knockdown of serum TTR with low inter-patient variability, with mean reductions of greater than 90% ...
With post hoc analysis, BridgeBio touts case for acoramidis as FDA decision date draws near After a single, 300-mg dose, mean serum TTR levels fell 90.3% at Day 15, 96.5% at Day 29 and 92.6% at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results